PLA2R1 and acute myeloid leukemia: PB samples of ALL and AML relapse also exhibited an increase in PLA2R1 methylation (27.1% ± 13.5%, p = 0.001) and relative blast cell numbers (21.3% ± 27.2%) in comparison to the control group.